NS
INMB icon

NBC Securities’s INmune Bio INMB Stock Holding History

NBC Securities’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-270
Closed -$2K – 2494
2025
Q1 		$2K Buy
+270
New +$2.14K ﹤0.01% 2029
2024
Q4 		– Sell
-270
Closed -$1K – 1658
2024
Q3 		$1K Hold
270
– – ﹤0.01% 2073
2024
Q2 		$2K Hold
270
– – ﹤0.01% 1987
2024
Q1 		$3K Hold
270
– – ﹤0.01% 1948
2023
Q4 		$3K Hold
270
– – ﹤0.01% 1957
2023
Q3 		$1K Buy
+270
New +$2.24K ﹤0.01% 2071

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

NBC Securities's INMB Position: Q2 2025 in Review

NBC Securities sold out of INmune Bio (INMB) in Q2 2025, closing a stake of 270 shares — an estimated $2K sold.

NBC Securities first reported a position in INMB in Q3 2023 and held it in 6 quarters. The position peaked at $3K in Q1 2024. 79 funds tracked by Wall St. Rank hold INMB as of Q2 2025.

  • NBC Securities reported no remaining INmune Bio position as of Q2 2025 after selling out during the quarter.
  • NBC Securities sold 270 INmune Bio shares in Q2 2025, an estimated $2K.
  • NBC Securities first reported a position in INmune Bio in Q3 2023 and held it in 6 quarters.
  • NBC Securities's INmune Bio position peaked at $3K in Q1 2024.
  • 79 funds tracked by Wall St. Rank held INmune Bio as of Q2 2025.

Based on NBC Securities's 13F filing for Q2 2025, filed 8 Jul 2025.